Microbix Presenting at Muskoka Capital Conference
Meetings with Growth-Oriented Investors, September 29 to October 1, 2023MISSISSAUGA, Ontario, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc....
Diagnostics
Biosenta Announces Breakthrough Discovery in Anti-Microbial Efficacy of Tri-Filler™ in Collaboration with Dr. Ian Lewis and Dr. Maen Husein’s Labs
TORONTO and CALGARY, Alberta, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. (“Biosenta” or the “Company”) (CSE: ZRO) is thrilled...
ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats
Provides Initial $59 Million and up to $168 Million Contingent on MilestonesNATICK, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) -- ModeX...
QIAGEN extends AI capabilities of its NGS interpretation software QCI Interpret to enable clinical exome completeness
AI-driven literature extraction for thousands of rare disease genes fortifies and extends QIAGEN’s proprietary, human-certified content, providing complete bibliographic coverage...
“The Future Is Bright” With Opportunities to Grow: BioAlberta’s State of the Industry Reports on Alberta’s Life Sciences and Healthcare Industry
EDMONTON, Alberta--(BUSINESS WIRE)--BioAlberta has published its 2023 State of the Industry (SOI) report. This year’s report includes new insights and...
Precipio Continues to Sign New HemeScreen™ Customers
New customer orders received in Q3 exceed $1M annualized revenueNEW HAVEN, Conn., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Specialty cancer...
QIAGEN’s QuantiFERON solutions recommended for use by kidney specialists in Tunisia
Tunisian Society of Nephrology first professional body in the field to publish nationwide guidanceAssociation of specialists recommends national immune response...
Renalytix Reports Full Year Fiscal 2023 Results
LONDON and SALT LAKE CITY, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled...
Update on MedMira’s Regulatory Path in Canada and the USA
HALIFAX, NS / ACCESSWIRE / September 27, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) provides an update on its progress...
GTG Signs Precision Medicine Pilot with Australia’s Largest Private Hospital Network
GeneType and Gold Coast Hospital Simon Morriss - Genetic Technologies Ltd CEO and Michelle Ferrari Cestari - Gold Coast Hospital...
Qualigen Therapeutics Presents Scientific Data on QN-302 at AACR Special Conference: Pancreatic Cancer 2023
Qualigen Therapeutics, Inc. Figure 1A Qualigen Therapeutics, Inc. Figure 1B Qualigen Therapeutics, Inc. Table 1Two posters include data on potential clinical biomarkers...
Teknova Launches Latest Proprietary AAV-Tek™ Product and End-to-End Plasmid Workflow Solutions to Streamline Therapeutic Process Development
Novel AEX screening kit – now available for AAV6 – and an expansive suite of high-quality reagents designed to expedite...
LIXTE Appoints Bas van der Baan as President and Chief Executive Officer
Lixte Biotechnology Holdings, Inc. Bas van der Baan, Newly Appointed President, CEO, Vice Chairman, LIXTE Biotechnology HoldingsBiotechnology Veteran Bas van...
LevelJump Healthcare Corp. Announces New Teleradiology Contract in Saskatchewan
Toronto, Ontario--(Newsfile Corp. - September 25, 2023) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("LevelJump" or the...
GE HealthCare Announces Cash Dividend for Third Quarter of 2023
CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC), a leading medical technology, pharmaceutical diagnostics, and digital...
Nanaz Mohtashami Elected to Hologic Board of Directors
MARLBOROUGH, Mass.--(BUSINESS WIRE)--$HOLX #boardofdirectors--Hologic, Inc. (Nasdaq: HOLX) announced today that Nanaz Mohtashami has been elected to the Company’s Board of...
New Mobile Medical Company Launches in Calgary to Provide Fast, Convenient Access to Lab Services
CALGARY, Alberta, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Mobile medical provider Scrubs Health Inc. (Scrubs™) is pleased to announce it...
Quantum-Si Appoints Biotech Executive and Entrepreneur, Amir Jafri, to its Board of Directors
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of...
Leading Experts Join 7th Annual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer
AdMeTech Foundation's 7th Annual Global Summit Brings Together the Key International Opinion Leaders for Accelerating Advancement of Research, Clinical Care...
Precipio Takes Final Step Towards Regaining Nasdaq Compliance
Company announces 1-for-20 reverse stock splitNEW HAVEN, Conn., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc....